Results 171 to 180 of about 65,815 (207)
Some of the next articles are maybe not open access.

Dipeptidyl peptidase-4-remmers (DPP-4-remmers)

Huisarts en wetenschap, 2013
die een behandeling met DPP-4-remmers kregen. De Cochrane-review liet geen significante verschillen zien tussen sitagliptine en vildagliptine vergeleken met andere orale antidiabetica.2 Een gerandomiseerd onderzoek rapporteerde significant minder hypoglykemieen (5%) met sitagliptine dan met glipizide (32%) dat was toegevoegd aan metformine.4 ...
openaire   +1 more source

Dipeptidyl Peptidase-4

RCSB Protein Data Bank, 2016
openaire   +2 more sources

Dipeptidyl Peptidase-4 – A Comprehensive Review

Current Enzyme Inhibition
Abstract: Type 2 diabetes mellitus is a growing global public health issue, with its prevalence projected to increase in the coming decades. It is one of the most prevalent and growing global health concerns, affecting millions of individuals worldwide.
V. Parthasarathi, Hemalatha K.
openaire   +1 more source

Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease

New England Journal of Medicine, 2021
Sherif S Farag   +2 more
exaly  

Dipeptidyl Peptidase-4 Inhibitors

2014
Ranjit Unnikrishnan   +2 more
openaire   +1 more source

Dipeptidyl peptidase-4 (DPP-4)

Science-Business eXchange, 2012
openaire   +1 more source

Periostin and Dipeptidyl Peptidase-4

Immunology and Allergy Clinics of North America, 2018
Claire Emson   +3 more
openaire   +1 more source

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2022
Ngoc-Yen T. Pham   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy